AzTrials
AzTrials

Coronary AngiographyHypCorNCT02818101

Hypnosis Efficacy for the Prevention of Anxiety During a Coronary Angiography

A study testing Hypnosis session in people with Coronary Angiography, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Coronary Angiography
What is being tested?
Hypnosis session
Could I receive a placebo?
No, everyone receives an active treatment
How many people
169 participants
Where
1 siteFrance
Study dates
Mar 2016to May 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • adult
  • coronary angiography scheduled with or without stenting
  • registered with a social security scheme
  • people informed clearly by the investigator

Who cannot join

  • coronary angiography already performed
  • not well french speaking and understanding
  • with functional disabilities (mental disorder, ...)
  • known background of schizophrenia
  • deaf or hard of hearing
  • patient under legally protection

Trial locations and contacts

1 site in 1 country.

France1 site
  • Chr Metz Thionville

    Metz, 57085

Other trials in France

About this study

The purpose of this study is to confirm the utility for hypnosis in the coronary angiographic examination. The technique would be an alternative to prevent the consumption of anesthesic drugs.

Read the detailed description

The coronary angiography is a medical imaging acquisition used in cardiology to highlight the coronary arteries after a coronary disease suspicion. According to an expert consensus it is performed under local anesthesia. Indeed the examination is quite painless, apart from the initial arterial puncture. Moreover, any patient chest pain must be detected during the examination to locate the guilty coronary injury. This is not possible with a patient under general anesthesia.

But, no general anesthesia may be a source of anxiety for patients, and the technique can be painful at several times: during the puncture, the exploration of probe into the winding, spastic or over-calcified arteries, or even during the dilation by the balloon swelling which obstructs downstream the artery.

The efficiency evaluation of the hypnosis made by INSERM in 2015 concludes that "the use of hypnosis during a surgical practice or during a medical or a interventional radiological act allows to reduce the consumption of sedative drugs and/or pain medication preoperatively".

The study hypothesis, is that hypnosis can contribute to a decreasing of anxiety and the pain for patients undergoing coronary angiography, and even a decreasing of complications due to a better control of hemodynamic (heart rate and blood pressure).

It could entail a better comfort for operator during the coronary angiography.

Primary objective :

To compare the initial anxiety state before the coronary angiographic performing scheduled for adults with no earlier coronary angiography, according to they will undergo a hypnotic session or not before the examination, with posthypnotic suggestions of self-hypnosis to make during the coronary angiography.

Secondary objective :

To compare between the two groups of patients:

  • pain during and after the coronary angiography
  • hemodynamic factors heart rate, blood pressure before and after the examination
  • operator comfort
  • use of sedative drugs, pain medication and local anesthesia
  • outbreak of major and minor complications

Primary endpoint :

Anxiety measured using self-report questionnaire (STAI-Y-A ), before coronary angiography

Secondary endpoints :

Trait anxiety (STAI-Y-B questionnaire) State anxiety the eve of coronary angiography Pain before and during the coronary angiography : Visual Analog Scale (VAS) Heart rate and blood pressure before and after the coronary angiography Comfort for the operator of the angiography : Likert scale into 5 points (1 : the worst comfort, 5 : the best possible comfort) Dose of sedative drugs, pain medication and local anesthesia injected during the coronary angiography Outbreak of major complications during the coronary angiography (death, stroke, tamponade, hemorrhagic shock, anaphylactic shock against the imaging tracer, ventricular tachycardia or ventricular fibrillation, severe bradycardia) or minor complications (vagal reaction, hematoma at the puncture point, skin allergy)

Methodology :

Efficiency comparative study, randomized, simple-blind (angiography operator in blind), single center, routine clinical care Only one medical check per patient

Procedures :

When a patient is taken over in cardiology department the eve of a scheduled coronary angiography, the cardiologist purposes them to take part in this study.

If they accept, a first evaluation of anxiety (trait and state) is performed. The following day, before going to the coronary angiography room, the patients are splitted randomly into two groups :

  • A group of patients which undergo a hypnotic session before examination with posthypnotic suggestions of self-hypnosis to be performed during the angiography. A medical prescription for anxiolytics can be made according to the patient clinical signs of anxiety
  • Another group becomes only a prescription of anxiolytics according to the patient clinical signs of anxiety.

The State Anxiety is measured after the setting of the patient in the coronary angiography room, before performing the examination. The pain and the hemodynamic factors are measured during and after the coronary angiography. The comfort of operator is evaluated too.

The patients will be contacted by phone one month after the coronary angiography to evaluate their satisfaction with their medical care.

Patients number :

Assuming that the control group has a mean score of 50 (standard deviation 10) with STAI-Y A, and a clinically significant difference (from 5 points), 85 patients must be included in each group, so totally 170 patients.

Trial Duration :

Expected study start: first semester of 2016 Inclusion duration: 12 months Duration per patient: 1 mois Total study duration: 18 months (including the data analysis et the report of results)

Statistical Analysis:

  • Primary objective: comparison of the mean scores STAI-Y A between the two groups (T test of Student), with adjustment on the potential factors of confusion (multiple linear regression)
  • Secondary objective: comparison of the quantitative criteria (T tests of Student) and qualitative criteria (Fischer's exact test) between the two groups.

Expected Benefits :

Since coronary angiography is an invasive procedure without general anesthesia affecting a noble organ, this procedure could be anxiogenic and even psychologically traumatic emergency. Not practice under general anesthesia prevents potential risks for the patient, but anxiety, non-comfort and pain are existing. We think that hypnosis could improve the patient care psychologically and physically and for any invasive procedure.

In this case, fewer or no sedative drugs and pain medication will be necessary, and it would decrease their potential iatrogenesis, the patient care will be improved. It will be an alternative for patient to decrease their drugs consumption.

Quality Assurance Plan :

Data will be recorded in a Paper Case Report from medical records. The patients will undergo only one medical examination for the study. No follow-up is expected.

Being tested
Hypnosis session

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypnosis sessionBehavioural

Study groups in NCT02818101
Study groupRoleWhat they receive
Control groupNo interventionNo hypnosis session before the coronary angiography
Hypnotised groupExperimentalHypnosis session before the coronary angiography
Receives: Behavioral: Hypnosis session

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State Anxiety

    Spielberger State-Trait Anxiety Inventory (STAI):

    Measured: 1 day

Secondary outcomes (6)
  1. Comfort for the operator of the angiography

    Likert scale into 5 points

    Measured: 1 day

  2. Pain

    visual analogue pain scale

    Measured: 1 day

  3. Heart rate

    beats per minute (bpm)

    Measured: 1 day

  4. Blood pressure

    mmHg

    Measured: 1 day

  5. Major complications

    beats per minutes

    Measured: 1 day

  6. dose of sedative drugs

    mg

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2016 (estimated)
  2. Study startMar 2016
  3. Primary completionJun 2017
  4. Study completionMay 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
169 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02818101
Sponsor's protocol ID
2016-02-CHRMT
Acronym
HypCor
Status last verified
Mar 2016
First submitted
30 Mar 2016
Last updated
24 Jun 2026
Results posted
No
Data monitoring committee
No

Publications

  • Abensur Vuillaume L, Gentilhomme C, Weber S, Ouamara N, Bayard J, Valla M, Khalife K, Goetz C, Guler N. Effectiveness of Hypnosis for the Prevention of Anxiety During Coronary Angiography (HYPCOR study): a prospective randomized study. BMC Complement Med Ther. 2022 Nov 29;22(1):315. doi: 10.1186/s12906-022-03792-x.

    PubMed 36447198

Questions about this trial

What is this clinical trial studying?

A study testing Hypnosis session in people with Coronary Angiography, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State Anxiety (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02818101, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in